Montermann, E.; Martin, H.; Grabbe, S. et al.
Determination of the tolerogenic potential of dexamethasone-treated antigen-presenting cells by in vivo MLREuropean Journal of Immunology. Bd. 39. H. 1. 2009 S. 652-652
von Stebut, E
Development of a vaccine for leishmaniasis - new from researchJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 7. 2009 S. 42-42
Reese, I; Zuberbier, T; Bunselmeyer, B et al.
Diagnostic approach for suspected pseudoallergic reaction to food ingredients.J Dtsch Dermatol Ges. Bd. 7. H. 1. 2009 S. 70-7
Boecken, G; Weitzel, T; Sunderkotter, C et al.
Diagnostik und Therapie der kutanen und mukokutanen Leishmaniasis in Deutschland.J Dtsch Dermatol Ges. Bd. 7 Suppl 7. 2009 S. s1-38
Klein-Tebbe, J.; Bufe, A.; Ebner, C. et al.
Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen ErkrankungenAllergo Journal. Bd. 18. 2009 S. 508-537
Höhn, Y.; Thamsen, M.; Wiechmann, N. et al.
Differentiation of murine DCs in the presence of a stable cAMP analougue results in the arisal of a protolerogenic DC populationEuropean Journal of Immunology. Bd. 39. H. 1. 2009 S. 650
Castor, T.; Wiechmann, N.; Besche, V. et al.
Differentiation of murine myeloid DC progenitors in the presence of glucocorticoid results in the induction of tolerogenic APCsEuropean Journal of Immunology. Bd. 39. H. 1. 2009 S. 649
Zuberbier, T; Asero, R; Bindslev-Jensen, C et al.
EAACI/GA superset of LEN/EDF/WAO guideline: management of urticariaALLERGY. Bd. 64. H. 10. 2009 S. 1427-1443
Zuberbier, T; Asero, R; Bindslev-Jensen, C et al.
EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticariaALLERGY. Bd. 64. H. 10. 2009 S. 1417-1426
Raker, V.; Barwig, C.; Montermann, E. et al.
Effect of co-expressiion of TGF-ß1 after gene gun-mediates DNA immunization on transgene-specific immune responsesEuropean Journal of Immunology. Bd. 39. H. 1. 2009 S. 549-549